Navigation Links
Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds

mas, and is active in an animal arthritis model Abstract #5398: 8:00 a.m. -12:00 p.m. Presenter: Lee Honigberg, Ph.D., Pharmacyclics, Inc. Session: Miscellaneous Anticancer Agents Poster Presentation: Synthesis and anticancer properties of water-soluble zinc ionophores Abstract #5606: 8:00 a.m. -12:00 p.m. Presenter: Darren Magda, Ph.D., Pharmacyclics, Inc.

Pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule drug development expertise to build a pipeline in oncology and other diseases based on a wide range of targets, pathways and mechanisms. Its lead product, Xcytrin(R) (motexafin gadolinium) Injection, has completed Phase 3 clinical trials and several ongoing Phase 1 and Phase 2 clinical trials are evaluating Xcytrin as a single agent or in combination with chemotherapy and/or radiation in multiple cancer types. More information about the company, its technology, and products can be found at www.pharmacyclics.com . Pharmacyclics(R), Xcytrin(R) and the "pentadentate" logo(R) are registered trademarks of Pharmacyclics, Inc.

NOTE: Other than statements of historical fact, the statements made in this press release about plans for our NDA filing, enrollment and future plans for our clinical trials, progress of and reports of results from preclinical and clinical studies, clinical development plans and product development activities are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. The words "believe," "will," "may," "continue," "plan," "expect," "intend," "anticipate," variations of such words, and similar expressions also identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. The forwar
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
2. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
3. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
4. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:4/24/2015)... April 24, 2015  Perrigo Company plc ("Perrigo" or ... of the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: ... shares of Perrigo for $60.00 per share in cash ... share (the "Offer").  The Board previously ... significantly undervalued the Company and its future growth prospects ...
(Date:4/24/2015)... April 24, 2015  New technologies and online ... to educate themselves about products and companies. Likewise, ... techniques available to market researchers seeking insights into ... marketplace, it,s imperative that organizations adjust their consumer ... market opportunities, niches and growth fronts. ...
(Date:4/24/2015)... DUBLIN , Apr. 24, 2015 Research and ... addition of the "Global Biobanking Market 2015-2019" ... the Global Biobanking market to grow at a CAGR ... Global Biobanking market can be divided into two segments: ... and the growth prospects of the Global Biobanking market ...
Breaking Medicine Technology:Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
... MUNDELEIN, Ill. , July 1 ... and information systems developer, today announces executive changes in ...  John Kershaw, President & CEO, Sysmex America Inc. has ... Secretary; Judy Bosko as Vice President of ...
... SCHAUMBURG, Ill. , July 1 ... today announced that the U.S. Food and Drug Administration ... sodium injection, USP. Heparin is a vital anticoagulant, preventing ... within the blood, routinely used in surgical and dialysis ...
Cached Medicine Technology:Sysmex America Announces Executive Leadership Changes 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 3FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 4
(Date:4/24/2015)... Carvers' goal is to help an ... day in Breck. , Conveniently located in the ... from Breckenridge, this family-owned place since 1995, has ... rentals ( http://www.breckenridgeskishop.com/en/rent-equipment ) and more. , ... in May 2015. With style and function progressing ...
(Date:4/24/2015)... Hollywood, CA (PRWEB) April 24, 2015 ... of sitting down in an interview with ItsNotAboutMe.TV contributor ... Choice Recovery, a holistic treatment center for addiction, of ... awards ceremonies and festivals throughout the year, the EcoLuxe ... top providers of eco-friendly and socially conscious products and ...
(Date:4/24/2015)... April 24, 2015 Anchor Health Administrators ... Field Professionals, today announced their exclusive agreement with LTC ... Term Care Insurance distribution partner. , Anchor has more ... Care Insurance benefits for associations, and is currently the ... Long Term Care Insurance member benefit. , “I ...
(Date:4/24/2015)... Joseph, Missouri (PRWEB) April 24, 2015 ... for veterinarians , UGA is now proud to be ... the care of 16,000 animals a year. This partnership ... care for their animals. , After providing an ... Missouri Veterinary Medical Teaching Hospital (VMTH) wanted to increase ...
(Date:4/24/2015)... 24, 2015 “ Opera ” was featured ... features the latest and coolest technology products available to consumers. ... conducted the review and shared with viewers how this is ... browsers, surfing the internet would not be in existence. But ... the Opera browser is no different. Celebrating their 20th anniversary ...
Breaking Medicine News(10 mins):Health News:Carvers Breckenridge Bike Rentals Offers Demo Mountain, Tandem, Bike Path Cruiser & JR. Bikes in May 2015 2Health News:Karen Salkin Talks with Per Wickstrom at the 2015 EcoLuxe Lounge and the "Salute to the Oscars" Celebration 2Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2
... and Safety Advantages Over Current Therapies, MARKHAM, ... data on a novel vitamin D analog, CTA018, ... of Nephrology (ASN) in Philadelphia.,In preclinical models, CTA018 ... replacement therapies, calcitriol and paricalcitol,(Zemplar(R)), the latter currently ...
... Statewide Initiative to,Advance Diabetes Screening for Medicare Beneficiaries, ... Casey Cagle today,applauded the design and implementation of ... it as a model for other cities in,Georgia ... at the Columbus Summit,a meeting hosted by the ...
... Pa., Nov. 6 Spectrum Control, Inc.,(Nasdaq: ... custom electronic,products and systems, announced today that its ... for a microwave integrated assembly used,in military tactical ... with additional orders and releases under the program,expected ...
... Animation,s "Madagascar: Escape 2 Africa(TM)" Happy Meal(TM) Event, ... one minute of fun,each day to help make a difference ... is asking kids and families as it launches One,Minute to ... kids to see what a difference a minute can make. ...
... Web cast live, LAVAL, QC, Nov. 6 /PRNewswire-FirstCall/ ... that on Tuesday, November 11, Mr. Gary,Schmid, President and ... owned subsidiary of BELLUS Health, will present a review ... 10th Annual Healthcare Conference to be held at the ...
... used with no other hormone therapy, is an effective ... 800 women from 65 centers in the United States, ... the study, the first to show that testosterone administered ... postmenopausal women. , Previous studies have shown testosterone ...
Cached Medicine News:Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 2Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 3Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 4Health News:Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model 5Health News:Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle 2Health News:Columbus Medicare Diabetes Screening Project Cited as Model for State by Lt. Governor Casey Cagle 3Health News:Spectrum Control Receives $1.2 Million Order for Microwave Integrated Assemblies 2Health News:McDonald's(R) Encourages Kids to Take One Minute to Move It 2Health News:McDonald's(R) Encourages Kids to Take One Minute to Move It 3Health News:McDonald's(R) Encourages Kids to Take One Minute to Move It 4Health News:BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference 2
The rubber, whistle tip catheter with thumb valve has two side eyes to help minimize trauma....
Gentle-Flo® Vactrol® Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
... 8 Suction Catheters With Contro-Vac Valve and ... Low-Risk Respiratory Suctioning, ,Medline's 6 and ... DeLee Tips are the optimal tools for ... a forward placed suction valve to minimize ...
... available in two tip styles- ... with staggered eyes, and the ... of catheter valve options, SAFE-T-VAC ... control with virtually no residual ...
Medicine Products: